Steatotic liver disease‐associated all‐cause/cause‐specific mortality in the United States

Documenti analoghi

• Association of High‐Sensitivity Troponins in Metabolic Dysfunction‐Associated Steatotic Liver Disease With All‐Cause and Cause‐Specific Mortality
  di: Donghee Kim, et al.
  Pubblicazione: (2025)
• Social Determinants of Health in Metabolic Dysfunction‐Associated Steatotic Liver Disease and All‐Cause/Cause‐Specific Mortality
  di: Donghee Kim, et al.
  Pubblicazione: (2025)
• Editorial: Understanding How Social Determinants of Health Impact Mortality in MASLD —Insights From a National Analysis. Authors' Reply
  di: Donghee Kim, et al.
  Pubblicazione: (2025)
• Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States
  di: Richie Manikat, et al.
  Pubblicazione: (2024)
• Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction‐associated steatotic liver disease
  di: Richie Manikat, et al.
  Pubblicazione: (2024)